Board Meeting25 Mar 2026, 06:01 pm
Pharmaids Pharmaceuticals Ltd Closes Trading Window for Designated Persons
AI Summary
Pharmaids Pharmaceuticals Ltd has announced the closure of the trading window for designated persons and their immediate relatives. This decision is in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct and Policies for Prevention of Insider Trading. The trading window will remain closed from April 01, 2026, till 48 hours after the declaration of Audited Financial Results of the Company for the Quarter and Year ended March 31, 2026. The date of the Board Meeting for consideration of the Audited Financial Results will be intimated in due course.
Key Highlights
- Pharmaids Pharmaceuticals Ltd closes trading window for designated persons and their immediate relatives
- Closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015
- Trading window to remain closed from April 01, 2026, till 48 hours after the declaration of Audited Financial Results
- The date of the Board Meeting for consideration of the Audited Financial Results will be intimated later
- Decision aims to ensure transparency and fairness in trading
Price Impact
More from PHARMAID